tinidazole + albendazole

A combination antiparasitic therapy consisting of tinidazole (a nitroimidazole antibiotic) and albendazole (a benzimidazole antiparasitic). This combination is primarily used for treating persistent parasitic infections, particularly **giardiasis**, that have failed to respond to conventional monotherapy [2]. It leverages the complementary antiparasitic mechanisms of both drugs. **Tinidazole** works by disrupting the DNA of susceptible organisms [7]. It is effective against protozoa like _Giardia_, _Trichomonas_, and _Entamoeba_ [4][6][9]. **Albendazole** primarily inhibits microtubule formation in parasites, affecting various helminthic infections (like tapeworms, hookworms) and also effective against protozoa like _Giardia_ [1][3]. When combined, they have shown enhanced effectiveness in treating refractory **giardiasis** after conventional treatment failure [2]. Combination therapy studies have demonstrated clinical cure in such patients [2]. The combination is generally well-tolerated. Side effects can include gastrointestinal disturbances, bitter taste, and nausea, with tinidazole potentially causing more side effects than albendazole [3][5][7][10]. Both should be avoided with alcohol due to the risk of disulfiram-like reactions [3][10]. This combination is particularly useful where first-line treatments fail, nitazoxanide is unavailable, or when co-infections with other sensitive parasites are present [2].